Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients.

NCT00445328 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00445328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients.
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2007
Completion date
July 31, 2008
Enrollment
84 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism